1,5-anhydroglucitol monitoring in diabetes: A mass balance perspective

被引:14
|
作者
Nerby, Craig L. [1 ]
Stickle, Douglas F. [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA
关键词
1,5-anhydroglucitol; Diabetes; ORAL GLUCOSE-TOLERANCE; TERM GLYCEMIC CONTROL; CHRONIC-RENAL-FAILURE; SERUM 1,5-ANHYDROGLUCITOL; PLASMA 1,5-ANHYDRO-D-GLUCITOL; CEREBROSPINAL-FLUID; URINARY-EXCRETION; CLINICAL MARKER; MELLITUS; EXCURSIONS;
D O I
10.1016/j.clinbiochem.2008.08.086
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
1,5-anhydroglucitol (AG) is a nonmetabolizable glucose analogue found in plasma due to ingestion. The normal steady-state concentration can be dramatically decreased by inhibition of tubular reabsorption during periods of hyperglycemia. For this reason, monitoring of AG has been plausibly advocated for detection of periodic glucosuric hyperglycemia. In this review, we examine the influence of variation in factors affecting both steady-state and transient changes in plasma AG. Among normals, the lower and upper limits of the plasma AG reference range vary by a factor of 5. Using a simplified mass balance model (a single compartment model with 3-6x larger-than-plasma volume of distribution), reasonable inter-individual variations of ingestion rate, glomerular filtration rate and fractional post-filtration reabsorption are each able to account for the wide range of normal, steady-state AG concentrations. In monitoring of changes in AG, inter-individual variations in the threshold for glucose excretion, volume of distribution and glomerular filtration rate are all likely to significantly affect correspondence of integral changes in AG to integral glucosuria/ hyperglycemia. This combination of variables, affecting both steady-state and transient changes, is significantly confounding with respect to interpretation of serial plasma AG concentrations. Resolution of information content of AG monitoring is thus largely that of crossing simple characterization of deltas [+,0,-] for changes in AG concentration against the information content of hemoglobin Alc monitoring. Despite this limitation, AG monitoring can in principle provide information about glycemic control in the short term that is not apparent through monitoring of hemoglobin Alc alone. However, whether AG monitoring can lead to improved outcomes in diabetes management remains to be established. (C) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 50 条
  • [1] A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control
    Stickle, D
    Turk, J
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (04): : E821 - E830
  • [2] 1,5-Anhydroglucitol in diabetes mellitus
    Won Jun Kim
    Cheol-Young Park
    Endocrine, 2013, 43 : 33 - 40
  • [3] 1,5-Anhydroglucitol in diabetes mellitus
    Kim, Won Jun
    Park, Cheol-Young
    ENDOCRINE, 2013, 43 (01) : 33 - 40
  • [4] Association of 1,5-Anhydroglucitol with Diabetes and Microvascular Conditions
    Selvin, Elizabeth
    Rawlings, Andreea M.
    Grams, Morgan
    Klein, Ronald
    Steffes, Michael
    Coresh, Josef
    CLINICAL CHEMISTRY, 2014, 60 (11) : 1409 - 1418
  • [5] 1,5-ANHYDROGLUCITOL AND NEONATAL COMPLICATIONS IN PREGNANCY COMPLICATED BY DIABETES
    Wright, Lorena A.
    Hirsch, Irl B.
    Gooley, Ted A.
    Brown, Zane
    ENDOCRINE PRACTICE, 2015, 21 (07) : 725 - 733
  • [6] 1,5-ANHYDROGLUCITOL - A NOVEL SERUM MARKER FOR SCREENING AND MONITORING DIABETES-MELLITUS
    FRATTALI, AL
    WOLF, BA
    CLINICAL CHEMISTRY, 1994, 40 (11) : 1991 - 1993
  • [7] 1,5-Anhydroglucitol: A new diagnostic test for gestational diabetes?
    Harper, Lorie M.
    Jauk, Victoria C.
    Biggio, Joseph R.
    Topham-Corley, Glenda
    Szychowski, Jeff M.
    Casey, Brian M.
    Tita, Alan T.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S271 - S272
  • [8] The clinical potential of 1,5-anhydroglucitol as biomarker in diabetes mellitus
    Xu, Haiying
    Chen, Renyin
    Hou, Xiaoli
    Li, Na
    Han, Yanwei
    Ji, Shaoping
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [9] Maternal and Neonatal Outcomes and 1,5-anhydroglucitol in Pregnancies Complicated by Diabetes
    Walker, Christie L.
    Hirsch, Irl B.
    Onstad, Lynn
    Gooley, Ted
    Brown, Zane
    Wright, Lorena A.
    DIABETES, 2017, 66 : LB55 - LB55
  • [10] Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control
    Yamanouchi, T
    Ogata, N
    Tagaya, T
    Kawasaki, T
    Sekino, N
    Funato, H
    Akaoka, I
    Miyashita, H
    LANCET, 1996, 347 (9014): : 1514 - 1518